Effect of social and climatological factors on antimicrobial use and Streptococcus pneumoniae resistance in different provinces in Spain

Journal of Antimicrobial Chemotherapy

Volumn 54, Issue 2, 2004, Pages 465-471

  García Rey, César ^a   Fennoll, Asunción ^b   Aguillar, Lorenzo ^a   Casal, Julio ^b  

^a GLAXOSMITHKLINE   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Antibiotic consumption; Resistance; S. pneumoniae

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; CEPHALOSPORIN DERIVATIVE; ERYTHROMYCIN; MACROLIDE; PENICILLIN G;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIUM ISOLATE; CLIMATE CHANGE; CLINICAL LABORATORY; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DRUG USE; ECONOMIC DEVELOPMENT; EDUCATION; GEOGRAPHIC DISTRIBUTION; HUMAN; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NONHUMAN; PENICILLIN RESISTANCE; POPULATION RISK; PREDICTION; PREVALENCE; SOCIAL ASPECT; SOCIOECONOMICS; SPAIN; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PNEUMONIAE;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ANTI-BACTERIAL AGENTS; CLIMATE; CULTURE; DRUG RESISTANCE, BACTERIAL; DRUG UTILIZATION; FEMALE; HEALTH RESOURCES; HUMANS; MALE; MIDDLE AGED; SOCIOECONOMIC FACTORS; SPAIN; STREPTOCOCCUS PNEUMONIAE;

EID: 4444367408     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/dkh375     Document Type: Article

References (22)

1. Moellering, R. C., Jr (1998). Problems with antimicrobial resistance in Gram-positive cocci. Clinical Infectious Diseases 26, 1177-8.
2. Felmingham, D. & Gruneberg, R. N. (2000). The Alexander Project 1996-1997: latest susceptibility data from this international study of bacterial pathogens from community-acquired lower respiratory tract infections. Journal of Antimicrobial Chemotherapy 45, 191-203.
3. Schappert, S. M. (1992). Office visits for otitis media: United States, 1975-90. Advance Data 214, 1-19.
4. Macfarlane, J. T., Colville, A., Guion, A. et al. (1993). Prospective study of aetiology and outcome of adult lower-respiratory-tract infections in the community. Lancet 341, 511-4.
5. Huovinen, P. & Cars, O. (1998). Control of antimicrobial resistance: time for action. The essentials of control are already well known. British Medical Journal 317, 613-4.
6. Baquero, F., Baquero-Artigao, G., Canton, R. et al. (2002). Antibiotic consumption and resistance selection in Streptococcus pneumoniae. Journal of Antimicrobial Chemotherapy 50, Suppl. C, 27-38.
7. Cars, O., Molstad, S. & Melander, A. (2001). Variation in antibiotic use in the European Union. Lancet 357, 1851-3.
8. Aguilar, L., Gimenez, M. J., Garcia-Rey, C. et al. (2002). New strategies to overcome antimicrobial resistance in Streptococcus pneumoniae with β-lactam antibiotics. Journal of Antimicrobial Chemotherapy 50, Suppl. C, 93-100.
9. Kristinsson, K. G. (1997). Effect of antimicrobial use and other risk factors on antimicrobial resistance in pneumococci. Microbial Drug Resistance 3, 117-23.
10. Cizman, M., Pokorn, M., Seme, K. et al. (2001). The relationship between trends in macrolide use and resistance to macrolides of common respiratory pathogens. Journal of Antimicrobial Chemotherapy 47, 475-7.
11. Garcia-Rey, C., Aguilar, L., Baquero, F. et al. (2002). Importance of local variations in antibiotic consumption and geographical differences of erythromycin and penicillin resistance in Streptococcus pneumoniae. Journal of Clinical Microbiology 40, 159-64.
12. Granizo, J. J., Aguilar, L., Casal, J. et al. (2000). Streptococcus pneumoniae resistance to erythromycin and penicillin in relation to macrolide and β-lactam consumption in Spain (1979-1997). Journal of Antimicrobial Chemotherapy 46, 767-73.
13. National Committee for Clinical Laboratory Standards (2002). Performance Standards For Antimicrobial Susceptibility Testing - Twelfth Informational Supplement: M100-S12. NCCLS, Vilanova, PA, USA.
14. Dantin, J. & Revenga, A. (1941). Las líneas y las zonas isóxeras de España segén los índices termopluviométricos. Avance al estudio de la aridez en Españ a. Estudios Geográficos 2, 35-91.
15. Perez-Trallero, E., Fernandez-Mazarrasa, C., Garcia-Rey, C. et al. (2001). Antimicrobial susceptibilities of 1,684 Streptococcus pneumoniae and 2,039 Streptococcus pyogenes isolates and their ecological relationships: results of a 1-year (1998-1999) multicenter surveillance study in Spain. Antimicrobial Agents and Chemotherapy 45, 3334-40.
16. Goldstein, F. W. (1999). Penicillin-resistant Streptococcus pneumoniae: selection by both β-lactam and non-β-lactam antibiotics. Journal of Antimicrobial Chemotherapy 44, 141-4.
17. McCormick, A. W., Whitney, C. G., Farley, M. M. et al. (2003). Geographic diversity and temporal trends of antimicrobial resistance in Streptococcus pneumoniae in the United States. Nature Medicine 9, 424-30.
18. Alou, L., Ramirez, M., Garcia-Rey, C. et al. (2001). Streptococcus pneumoniae isolates with reduced susceptibility to ciprofloxacin in Spain: clonal diversity and appearance of ciprofloxacin- resistant epidemic clones. Antimicrobial Agents and Chemotherapy 45, 2955-7.
19. Alberti, S., Garcia-Rey, C., Dominguez, M. A. et al. (2003). Survey of emm gene sequences from pharyngeal Streptococcus pyogenes isolates collected in Spain and their relationship with erythromycin susceptibility. Journal of Clinical Microbiology 41, 2385-90.
20. Perez-Trallero, E., Marimon, J. M., Gonzalez, A. et al. (2003). Genetic relatedness of recently collected Spanish respiratory tract Streptococcus pneumoniae isolates with reduced susceptibility to amoxicillin. Antimicrobial Agents and Chemotherapy 47, 3637-9.
21. Baquero, F. (1996). Trends in antibiotic resistance of respiratory pathogens: an analysis and commentary on a collaborative surveillance study. Journal of Antimicrobial Chemotherapy 38, 117-32.
22. Negri, M. C., Morosini, M. I., Loza, E. et al. (1994). In vitro selective antibiotic concentrations of β-lactams for penicillin-resistant Streptococcus pneumoniae populations. Antimicrobial Agents and Chemotherapy 38, 122-5.